Skip to content
★ Sign in to follow
BD

Bryan D. Olin

Executive
Cyberonics Inc
Total declarations
28
Company
1
▲ Purchases (3 ops.)
€400k
▼ Sales (7 ops.)
€2.8M

Latest filing published 13 Jun 2014 for CYBERONICS INC, €430k.

Insider track record

Disclosed buys
3
Disclosed sells
7
Signal history

No signal scores available.

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Bryan D. Olin: trading record in brief

All filings by Bryan D. Olin on record concern Cyberonics Inc. We count 28 filings; the first trade dates from 8 June 2009 and the latest from 11 June 2014.

Both buying and selling appear: 3 purchases worth €400k, against 7 sales worth €2.8M. Netting one side against the other leaves €2.4M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 14 share grants and 4 option exercises. In 2014 alone, the filings show no purchases and 2 sales.

A typical purchase (the median) is worth €114k.

The record was last updated on 13 June 2014 with an open-market sale (€430k) in Cyberonics Inc. The last purchase on record was published on 20 December 2012, which is 5,072 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Bryan D. Olin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations28 total
  • ▼
    VP Clinical Quality RegulatoryExecutivesCyberonics Inc
    581,700 USD0SEC
    10,000 shares@ US$58.17Common StockSEC:0001140361-14-025667:0
  • ◇
    VP Clinical Quality RegulatoryExecutivesCyberonics Inc
    62,560 USD0SEC
    4,250 shares@ US$14.72Common StockSEC:0001140361-14-010103:0
  • ◇
    VP Clinical Quality RegulatoryExecutivesCyberonics Inc
    74,985 USD0SEC
    3,082 shares@ US$24.33Common StockSEC:0001140361-14-010103:1
  • ◇
    VP Clinical Quality RegulatoryExecutivesCyberonics Inc
    85,871 USD0SEC
    3,340 shares@ US$25.71Common StockSEC:0001140361-14-010103:2
  • ▼
    VP Clinical Quality RegulatoryExecutivesCyberonics Inc
    729,324 USD0SEC
    10,672 shares@ US$68.34Common StockSEC:0001140361-14-010103:3
  • ◆
    VP Clinical Quality RegulatoryExecutivesCyberonics Inc
    0SEC
    888 sharesCommon StockSEC:0001140361-13-026037:0
  • ◆
    VP Clinical Quality RegulatoryExecutivesCyberonics Inc
    0SEC
    1,019 sharesCommon StockSEC:0001140361-13-026037:1
  • ◆
    VP Clinical Quality RegulatoryExecutivesCyberonics Inc
    0SEC
    1,686 sharesCommon StockSEC:0001140361-13-025629:0
  • ◆
    VP Clinical Quality RegulatoryExecutivesCyberonics Inc
    0SEC
    3,131 sharesCommon StockSEC:0001140361-13-025629:1
  • ◇
    VP Clinical Quality RegulatoryExecutivesCyberonics Inc
    103,040 USD0SEC
    7,000 shares@ US$14.72Common StockSEC:0001140361-13-025247:0
  • ▼
    VP Clinical Quality RegulatoryExecutivesCyberonics Inc
    366,100 USD0SEC
    7,000 shares@ US$52.30Common StockSEC:0001140361-13-025247:1
  • ▲
    VP, QualityExecutivesCyberonics Inc
    149,994 USD0SEC
    6,165 shares@ US$24.33Common StockSEC:0001140361-12-052086:0
    Canonical exit: 18 Mar 2013 (T+90)
  • ▲
    VP, QualityExecutivesCyberonics Inc
    85,871 USD0SEC
    3,340 shares@ US$25.71Common StockSEC:0001140361-12-052086:1
    Canonical exit: 18 Mar 2013 (T+90)
  • ▼
    VP, QualityExecutivesCyberonics Inc
    493,214 USD0SEC
    9,505 shares@ US$51.89Common StockSEC:0001140361-12-052086:2
  • ▼
    VP, QualityExecutivesCyberonics Inc
    927,938 USD0SEC
    18,750 shares@ US$49.49Common StockSEC:0001140361-12-039050:1
  • ▲
    VP, QualityExecutivesCyberonics Inc
    276,000 USD0SEC
    18,750 shares@ US$14.72Common StockSEC:0001140361-12-039050:0
    Canonical exit: 28 Nov 2012 (T+90)
  • ◆
    VP, QualityExecutivesCyberonics Inc
    0SEC
    3,339 sharesCommon StockSEC:0001140361-12-030487:0
  • ◆
    VP, QualityExecutivesCyberonics Inc
    0SEC
    888 sharesCommon StockSEC:0001140361-12-030487:1
  • ◆
    VP, QualityExecutivesCyberonics Inc
    0SEC
    1,184 sharesCommon StockSEC:0001140361-12-030487:2
  • ◆
    VP, QualityExecutivesCyberonics Inc
    0SEC
    4,226 sharesCommon StockSEC:0001140361-12-029699:0
  • ◆
    VP Clinical Reg & QualityExecutivesCyberonics Inc
    204,608 USD0SEC
    13,900 shares@ US$14.72Common StockSEC:0001140361-12-014356:0
  • ▼
    VP Clinical Reg & QualityExecutivesCyberonics Inc
    515,829 USD0SEC
    13,900 shares@ US$37.11Common StockSEC:0001140361-12-014356:1
  • ◆
    VP Clinical Reg & QualityExecutivesCyberonics Inc
    16,192 USD0SEC
    1,100 shares@ US$14.72Common StockSEC:0001140361-12-014356:2
  • ▼
    VP Clinical Reg & QualityExecutivesCyberonics Inc
    41,316 USD0SEC
    1,100 shares@ US$37.56Common StockSEC:0001140361-12-014356:3
  • ◆
    VP Clinical Quality RegulatoryExecutivesCyberonics Inc
    0SEC
    6,680 sharesCommon StockSEC:0001140361-11-033410:0

25 of 28 declarations